Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer

Kapiteijn, 2001, Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580 Swedish Rectal Cancer Trial, 1997, Improved survival with preoperative radiotherapy in resectable rectal cancer, N Engl J Med, 336, 980, 10.1056/NEJM199704033361402 Heald, 1986, Recurrence and survival after total mesorectal excision for rectal cancer, Lancet, 1, 1479, 10.1016/S0140-6736(86)91510-2 MacFarlane, 1993, Mesorectal excision for rectal cancer, Lancet, 341, 457, 10.1016/0140-6736(93)90207-W Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, NEJM, 351, 1731, 10.1056/NEJMoa040694 Van Gijn, 2011, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial, Lancet Oncol, 12, 575, 10.1016/S1470-2045(11)70097-3 Sebag-Montefiore, 2009, Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial, Lancet, 373, 811, 10.1016/S0140-6736(09)60484-0 Sineshaw, 2016, Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: an analysis from the national cancer data base, Cancer, 122, 1996, 10.1002/cncr.29993 PelvEx Collaborative, 2021, Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology: results from the PelvEx Collaborative, BJS Open, 5, 10.1093/bjsopen/zraa055 Gietelink, 2016, Dutch Surgical Colorectal Cancer Audit Group. The influence of hospital volume on circumferential resection margin involvement: results of the Dutch Surgical Colorectal Audit, Ann Surg, 263, 745, 10.1097/SLA.0000000000001009 Patel, 2011, Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience, J Clin Oncol, 29, 10.1200/JCO.2011.34.9068 Australian Institute of Health and Welfare, 2009 Kokelaar, 2016, Locally advanced rectal cancer: management challenges, OncoTargets Ther, 13, 6265, 10.2147/OTT.S100806 Brown, 2017, Pelvic exenteration surgery: the evolution of radical surgical techniques for advanced and recurrent pelvic malignancy, Dis Colon Rectum, 60, 745, 10.1097/DCR.0000000000000839 PelvEx Collaborative, 2019, Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer, BJS Open, 3, 516, 10.1002/bjs5.50153 Waters, 2019, Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades, Eur J Surg Oncol, 45, 2325, 10.1016/j.ejso.2019.07.015 2021 Altman, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluatehealthcare interventions: explanation and elaboration, BMJ, 339, b2700, 10.1136/bmj.b2700 PelvEx Collaborative, 2019, Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration, Ann Surg, 269, 315, 10.1097/SLA.0000000000002528 Peacock, 2019, Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era, Br J Surg, 106, 1685, 10.1002/bjs.11242 Quyn, 2016, Outcomes of pelvic exenteration for locally advanced primary rectal cancer: overall survival and quality of life, Eur J Surg Oncol, 42, 823, 10.1016/j.ejso.2016.02.016 Kusters, 2014, Survival after pelvic exenteration for T4 rectal cancer, Br J Surg, 102, 125, 10.1002/bjs.9683 Radwan, 2015, Determinants of survival following pelvic exenteration for primary rectal cancer, Br J Surg, 102, 1278, 10.1002/bjs.9841 Bhangu, 2014, Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer, Ann Surg, 259, 315, 10.1097/SLA.0b013e31828a0d22 Nielsen, 2012, A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database, Colorectal Dis, 14, 1076, 10.1111/j.1463-1318.2011.02893.x Ishiguro, 2009, Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period, Surgery, 145, 189, 10.1016/j.surg.2008.09.014 Derici, 2008, Multivisceral resections for locally advanced rectal cancer, Colorectal Dis, 10, 453, 10.1111/j.1463-1318.2007.01427.x Vermaas, 2007, Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer, Eur J Surg Oncol, 33, 452, 10.1016/j.ejso.2006.09.021 Eriksen, 2006, Surgical treatment of primary locally advanced rectal cancer in Norway, Eur J Surg Oncol, 32, 174, 10.1016/j.ejso.2005.10.008 Kecmanovic, 2003, Management of advanced pelvic cancer by exenteration, Eur J Surg Oncol, 29, 743, 10.1016/j.ejso.2003.08.008 Moriya, 2003, Aggressive surgical treatment for patients with T4 rectal cancer, Colorectal Dis, 5, 427, 10.1046/j.1463-1318.2003.00511.x Yamada, 2002, Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer, Dis Colon Rectum, 45, 1078, 10.1007/s10350-004-6363-1 Lau, 2019, Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer, Br J Surg, 106, 484, 10.1002/bjs.11048 Pareekutty, 2019, En bloc resection with partial sacrectomy helps to achieve R0 resection in locally advanced rectal cancer, experience from a tertiary cancer center, Indian J Surg Oncol, 10, 141, 10.1007/s13193-018-0837-4 Milne, 2014, Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies, Dis Colon Rectum, 57, 1153, 10.1097/DCR.0000000000000196 Bosman, 2014, Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer, Eur J Surg Oncol, 40, 699, 10.1016/j.ejso.2014.02.233 Bhangu, 2012, Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer, Br J Surg, 99, 1453, 10.1002/bjs.8881 Ferenschild, 2009, Abdominosacral resection for locally advanced and recurrent rectal cancer, Br J Surg, 96, 1341, 10.1002/bjs.6695 Bebenek, 2009, Abdominosacral amputation of the rectum for low rectal cancers: ten years of experience, Ann Surg Oncol, 16, 2211, 10.1245/s10434-009-0517-2 Larach, 2021, Beyond taTME: short-term outcomes of taTME in locally advanced rectal cancer requiring resection beyond total mesorectal excision, Colorectal Dis, 23, 823, 10.1111/codi.15446 Solomon, 2015, Lateral pelvic compartment excision during pelvic exenteration, Br J Surg, 102, 1710, 10.1002/bjs.9915 Austin, 2009, Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement, Dis Colon Rectum, 52, 1223, 10.1007/DCR.0b013e3181a73f48 Moriya, 1988, En bloc excision of lower ureter and internal iliac vessels for locally advanced upper rectal and rectosigrnoid cancer use of ileal segment for ureteral repair, Dis Colon Rectum, 31, 872, 10.1007/BF02554852 Nonaka, 2021, Feasibility of laparoscopic-assisted transanal pelvic exenteration in locally advanced rectal cancer with anterior invasion, Tech Coloproctol, 25, 69, 10.1007/s10151-020-02324-4 Tashiro, 2021, Surgical outcomes of hybrid hand-assisted laparoscopic pelvic exenteration for locally advanced rectal cancer: initial experience, Asian J Endosc Surg, 14, 213, 10.1111/ases.12855 Kumar, 2020, Minimally invasive surgery for pelvic exenteration in primary colorectal cancer, J Soc Laparoendosc Surg, 24 Nishikawa, 2019, Short- and long-term outcomes of minimally invasive versus open multivisceral resection for locally advanced colorectal cancer, Dis Colon Rectum, 62, 40, 10.1097/DCR.0000000000001255 Porkharkar, 2018, Laparoscopic pelvic exenteration for locally advanced rectal cancer, technique and short-term outcomes, J Laparoendosc Adv Surg Tech, 28, 1489, 10.1089/lap.2018.0147 Hida, 2018, Open versus laparoscopic surgery for advanced low rectal cancer: a large, multicenter, propensity score matched cohort study in Japan, Ann Surg, 268, 318, 10.1097/SLA.0000000000002329 Nonaka, 2018, The feasibility and efficacy of laparoscopic extended total mesorectal excision for locally advanced lower rectal cancer, vol. 32, 643 Smith, 2020, Robotic multivisceral pelvic resection: experience from an exenteration unit, Tech Coloproctol, 24, 1145, 10.1007/s10151-020-02290-x Rohila, 2020, Evolution of robotic surgery in a colorectal cancer unit in India, Indian J Surg Oncol, 11, 633, 10.1007/s13193-020-01105-7 Crolla, 2018, Robot-assisted laparoscopic resection of clinical T4b tumours of distal sigmoid and rectum: initial results, Surg Endosc, 32, 4571, 10.1007/s00464-018-6210-4 Yamaguchi, 2018, Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer, Surg Endosc, 32, 4498, 10.1007/s00464-018-6197-x Hino, 2017, Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center, Tech Colporoctol, 21, 879, 10.1007/s10151-017-1710-0 Shin, 2016, Oncologic outcomes of extended robotic resection for rectal cancer, Ann Surg Oncol, 23, 2249, 10.1245/s10434-016-5117-3 Sauer, 2012, Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years, J Clin Oncol, 30, 1926, 10.1200/JCO.2011.40.1836 Peeters, 2007, The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma, Ann Surg, 246, 693, 10.1097/01.sla.0000257358.56863.ce Bosset, 2006, Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, 355, 1114, 10.1056/NEJMoa060829 Bahadoer, 2021, Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial, Lancet Oncol, 22, 29, 10.1016/S1470-2045(20)30555-6 Zhang, 2018, Total neoadjuvant treatment versus chemoradiotherapy in locally advanced rectal cancer: a propensity score analysis from two prospective phase II clinical trials, J Clin Oncol, 36 Cercek, 2018, Adoption of total neoadjuvant therapy for locally advanced rectal cancer, JAMA Oncol, 4, 10.1001/jamaoncol.2018.0071 Young, 2014, Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy, Br J Surg, 101, 277, 10.1002/bjs.9392 Venchiarutti, 2019, Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity, Br J Surg, 106, 1393, 10.1002/bjs.11203 PelvEx Collaborative, 2018, Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer, Br J Surg, 105, 65, 10.1002/bjs.10734 Sugarbaker, 1982, Partial sacrectomy for en bloc excision of rectal cancer with posterior fixation, Dis Colon Rectum, 25, 708, 10.1007/BF02629545 Pearlman, 1987, Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer, Arch Surg, 122, 537, 10.1001/archsurg.1987.01400170043006 Shaikh, 2016, Complex Cancer Clinic St. Mark's Hospital London. High subcortical sacrectomy: a novel approach to facilitate complete resection of locally advanced and recurrent rectal cancer with high (S1-S2) sacral extension, Colorectal Dis, 18, 386, 10.1111/codi.13226 Magrini, 1996, Sacropelvic resection and intraoperative electron irradiation in the management of recurrent anorectal cancer, Dis Colon Rectum, 39, 1, 10.1007/BF02048260 Wanebo, 1987, Pelvic recurrence of rectal cancer. Options for curative resection, Ann Surg, 205, 482, 10.1097/00000658-198705000-00006 Chau, 2017, Persistent perineal sinus after abdominoperineal resection, Langenbeck's Arch Surg, 402, 1063, 10.1007/s00423-017-1619-0 Davidge, 2011, Qualitative assessment of patient experiences following sacrectomy, J Surg Oncol, 101, 447 Bianchi, 1999, Vascular reconstruction and major resection for malignancy, Arch Surg, 134, 851, 10.1001/archsurg.134.8.851 Peacock, 2020, Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis, Colorectal Dis, 22, 818, 10.1111/codi.14969 Peacock, 2021, Preemptive femoral-femoral crossover grafting of artery and vein before pelvic exenterative surgery for locally advanced and recurrent pelvic malignancy involving the aortoiliac Axis, Dis Colon Rectum, 64, e2, 10.1097/DCR.0000000000001819 Guren, 2015, Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993 – 2010, Acta Oncol, 54, 1714, 10.3109/0284186X.2015.1034876 Prades, 2016, Improving clinical outcomes through centralization of rectal cancer surgery and clinical audit: a mixed-methods assessment, Eur J Publ Health, 26, 538, 10.1093/eurpub/ckv237 Hallet, 2021, Association between anesthesiologist volume and short-term outcomes in complex gastrointestinal cancer surgery, JAMA Surg, 156, 479, 10.1001/jamasurg.2021.0135 McArdle, 2004, Influence of volume and specialization on survival following surgery for colorectal cancer, Br J Surg, 91, 610, 10.1002/bjs.4476 Holm, 1997, Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy, Br J Surg, 84, 657 Iversen, 2007, Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome, Colorectal Dis, 9, 38, 10.1111/j.1463-1318.2006.01095.x Hosseinaili Khani, 2010, Centralization of rectal cancer surgery improves long-term survival, Colorectal Dis, 12, 874, 10.1111/j.1463-1318.2009.02098.x Archampong, 2012, Workload and surgeon's specialty for outcome after colorectal cancer surgery, Cochrane Database Syst Rev El Amrani, 2018, The impact of hospital volume and charlson score on postoperative mortality of proctectomy for rectal cancer - a nationwide study of 45,569 patients, Ann Surg, 268, 854, 10.1097/SLA.0000000000002898 Birkmeyer, 2002, Hospital volume and surgical mortality in the United States, N Engl J Med, 346, 1128, 10.1056/NEJMsa012337 McPhee, 2007, Perioperative mortality for pancreatectomy, Ann Surg, 246, 246, 10.1097/01.sla.0000259993.17350.3a Pal, 2008, Volume and outcome for major upper GI surgery in england, J Gastrointest Surg, 12, 353, 10.1007/s11605-007-0288-7 Sheetz, 2019, Centralization of high-risk cancer surgery within existing hospital systems, J Clin Oncol, 37, 3234, 10.1200/JCO.18.02035 Matsuo, 2020, Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies, J Surg Oncol, 121, 402, 10.1002/jso.25770